Results of Nurse Navigator Follow-up After Positive Colorectal Cancer Screening Test: A Randomized Trial

被引:48
作者
Green, Beverly B. [1 ,2 ]
Anderson, Melissa L. [1 ,2 ]
Wang, Ching-Yun [4 ]
Vernon, Sally W. [5 ]
Chubak, Jessica [1 ,2 ,3 ]
Meenan, Richard T. [6 ]
Fuller, Sharon [1 ,2 ]
机构
[1] Grp Hlth Cooperat Puget Sound, Seattle, WA USA
[2] Grp Hlth Res Inst, Seattle, WA 98101 USA
[3] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
[4] Fred Hutchinson Canc Ctr, Seattle, WA USA
[5] Univ Texas Houston, Ctr Hlth Promot & Prevent Res, Sch Publ Hlth, Houston, TX USA
[6] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA
关键词
Cancer Screening; Colonoscopy; Colorectal Cancer; Patient Navigators; OCCULT BLOOD-TEST; PATIENT NAVIGATION; DIAGNOSTIC EVALUATION; CARE; INTERVENTION; RESOLUTION; MORTALITY; IMPROVE;
D O I
10.3122/jabfm.2014.06.140125
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Follow-up after a positive colorectal cancer screening test is necessary for screening to be effective. We hypothesized that nurse navigation would increase the completion of colonoscopy after a positive screening test. Methods: This study was conducted between 2008 and 2012 at 21 primary care medical centers in western Washington State. Participants in the Systems of Support to Increase Colorectal Cancer Screening study who had a positive fecal occult blood test (FOBT) or flexible sigmoidoscopy needing follow-up were randomized to usual care (UC) or a nurse navigator (navigation). UC included an electronic health record-based positive FOBT registry and physician reminder system. Navigation included UC plus care coordination and patient self-management support from a registered nurse who tracked and assisted patients until they completed or refused colonoscopy. The primary outcome was completion of colonoscopy within 6 months. After 6 months, both groups received navigation. Results: We randomized 147 participants with a positive FOBT or sigmoidoscopy. Completion of colonoscopy was higher in the intervention group at 6 months, but differences were not statistically significant (91.0% in navigation group vs 80.8% in UC group; adjusted difference, 10.1%; P = .10). Reasons for no or late colonoscopies included refusal, failure to schedule or missed appointments, concerns about risks or costs, and competing health concerns. Conclusions: Navigation did not lead to a statistically significant incremental benefit at 6 months. Impact: Follow-up rates after a positive colorectal cancer (CRC) screening test are high in a health care system where UC included a registry and physician reminders. Because of high follow-up rates in a health care system where UC included a registry and physician reminders, and small sample size, we cannot rule out incremental benefits of nurse navigation.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 24 条
[1]   Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result [J].
Baig, N ;
Myers, RE ;
Turner, BJ ;
Grana, J ;
Rothermel, T ;
Schlackman, N ;
Weinberg, DS .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (09) :2078-2081
[2]   Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test [J].
Ferrat, E. ;
Le Breton, J. ;
Veerabudun, K. ;
Bercier, S. ;
Brixi, Z. ;
Khoshnood, B. ;
Paillaud, E. ;
Attali, C. ;
Bastuji-Garin, S. .
BRITISH JOURNAL OF CANCER, 2013, 109 (06) :1437-1444
[3]   An Automated Intervention With Stepped Increases in Support to Increase Uptake of Colorectal Cancer Screening A Randomized Trial [J].
Green, Beverly B. ;
Wang, Ching-Yun ;
Anderson, Melissa L. ;
Chubak, Jessica ;
Meenan, Richard T. ;
Vernon, Sally W. ;
Fuller, Sharon .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (05) :301-311
[4]   Systems of support to increase colorectal cancer screening and follow-up rates (SOS): Design, challenges, and baseline characteristics of trial participants [J].
Green, Beverly B. ;
Wang, C. Y. ;
Homer, Kathryn ;
Catz, Sheryl ;
Meenan, Richard T. ;
Vernon, Sally W. ;
Carrell, David ;
Chubak, Jessica ;
Ko, Cynthia ;
Laing, Sharon ;
Bogart, Andy .
CONTEMPORARY CLINICAL TRIALS, 2010, 31 (06) :589-603
[5]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[6]   Prevalence of Adenomas and Colorectal Cancer in Average Risk Individuals: A Systematic Review and Meta-analysis [J].
Heitman, Steven J. ;
Ronksley, Paul E. ;
Hilsden, Robert J. ;
Manns, Braden J. ;
Rostom, Alaa ;
Hemmelgarn, Brenda R. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (12) :1272-1278
[7]   Improving the Follow-Up of Positive Hemoccult Screening Tests: An Electronic Intervention [J].
Humphrey, Linda L. ;
Shannon, Jackilen ;
Partin, Melissa R. ;
O'Malley, Jean ;
Chen, Zunqiu ;
Helfand, Mark .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (07) :691-697
[8]  
Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881
[9]   Omission-related malpractice claims and the limits of defensive medicine [J].
Kravitz, RL ;
Rolph, JE ;
Petersen, L .
MEDICAL CARE RESEARCH AND REVIEW, 1997, 54 (04) :456-471
[10]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471